P06241

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession FYN_HUMAN; P06241;
Entrez ID 2534
GenBank Protein ID NM_002037.5; NM_153047.3; NM_153048.3; XM_005266890.3; XM_005266892.3; XM_017010650.1; XM_017010651.1; XM_017010652.1; XM_017010653.1; XM_017010654.1;
GenBank Nucleotide ID NP_002028.1; NP_694592.1; NP_694593.1; XP_005266947.1; XP_005266949.1; XP_016866139.1; XP_016866140.1; XP_016866141.1; XP_016866142.1; XP_016866143.1;
Protein Name Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn)
Gene Name FYN
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionNon-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance. Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain. Following activation by PKA, the protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions. Involved in the regulation of cell adhesion and moti(view all)
Sequence
(Fasta)
MGCVQCKDKE ATKLTEERDG SLNQSSGYRY GTDPTPQHYP SFGVTSIPNY NNFHAAGGQG 60
LTVFGGVNSS SHTGTLRTRG GTGVTLFVAL YDYEARTEDD LSFHKGEKFQ ILNSSEGDWW 120
EARSLTTGET GYIPSNYVAP VDSIQAEEWY FGKLGRKDAE RQLLSFGNPR GTFLIRESET 180
TKGAYSLSIR DWDDMKGDHV KHYKIRKLDN GGYYITTRAQ FETLQQLVQH YSERAAGLCC 240
RLVVPCHKGM PRLTDLSVKT KDVWEIPRES LQLIKRLGNG QFGEVWMGTW NGNTKVAIKT 300
LKPGTMSPES FLEEAQIMKK LKHDKLVQLY AVVSEEPIYI VTEYMNKGSL LDFLKDGEGR 360
ALKLPNLVDM AAQVAAGMAY IERMNYIHRD LRSANILVGN GLICKIADFG LARLIEDNEY 420
TARQGAKFPI KWTAPEAALY GRFTIKSDVW SFGILLTELV TKGRVPYPGM NNREVLEQVE 480
RGYRMPCPQD CPISLHELMI HCWKKDPEER PTFEYLQSFL EDYFTATEPQ YQPGENL 538

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1Tyrosine PhosphorylationSquamous cell carcinomaUY42019934324
[Reference]: Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.

※ Disease Cross-ref Annotation

DatabaseAnnotation
CTD (Curated)
(count: 5)
MESH:D002375 ; Catalepsy
MESH:D015459 ; Leukemia-Lymphoma, Adult T-Cell
MESH:D008106 ; Liver Cirrhosis, Experimental
MESH:D016411 ; Lymphoma, T-Cell, Peripheral
MESH:D013274 ; Stomach Neoplasms
DisGeNet (Curated)
(count: 10)
(view all)
C0001969; Alcoholic Intoxication
C0001973; Alcoholic Intoxication, Chronic
C0005586; Bipolar Disorder
C0007370; Catalepsy
C0023493; Adult T-Cell Lymphoma/Leukemia
C0023893; Liver Cirrhosis, Experimental
GWASdb
(count: 30)
(view all)
rs9320374; Breast cancer; breast cancer
rs6919400; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs2237255; Response to statin treatment (atorvastatin), change in cholesterol levels; cardiovascular system disease
rs9374274; Coronary heart disease; coronary artery disease
rs9374274; Insulin Resistance; type 2 diabetes mellitus
rs9374274; Insulin-related traits; type 2 diabetes mellitus

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 34)
(view all)
12        QCKDKEATKLTEERD     dbPAF
15        DKEATKLTEERDGSL     dbPAF
178       GTFLIRESETTKGAY     dbPAF
181       LIRESETTKGAYSLS     dbPAF
185       SETTKGAYSLSIRDW     dbPAF
186       ETTKGAYSLSIRDWD     dbPAF
Acetylation
(count: 1)
427       YTARQGAKFPIKWTA     PLMD
Ubiquitination
(count: 10)
(view all)
13        CKDKEATKLTEERDG     PLMD
153       AEEWYFGKLGRKDAE     PLMD
182       IRESETTKGAYSLSI     PLMD
207       VKHYKIRKLDNGGYY     PLMD
259       RLTDLSVKTKDVWEI     PLMD
295       GTWNGNTKVAIKTLK     PLMD
Malonylation
(count: 1)
427       YTARQGAKFPIKWTA     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource